𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiogenesis inhibitors in the treatment of non-small-cell lung cancer (NSCLC)

✍ Scribed by Enric Carcereny Costa; Núria Viñolas Segarra; Pere Gascón Vilaplana

Book ID
107596340
Publisher
Springer Milan
Year
2008
Tongue
Spanish
Weight
153 KB
Volume
10
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor angiogenesis of non–small cell lun
Tumor angiogenesis of non–small cell lung cancer
✍ Noriharu Shijubo; Hiroshi Kojima; Manabu Nagata; Takashi Ohchi; Akihiro Suzuki; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract Lung cancer is one of the commonest causes of cancer death in developed countries. Recent evidence suggests that angoigenesis is related to poor prognosis in many solid tumors including non–small cell lung cancer (NSCLC). Angiogenesis is regulated by a complex interaction among growth f

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPER
PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON-SMALL CELL LUNG CANCER
✍ ALEXANDRA GIATROMANOLAKI; MICHAEL KOUKOURAKIS; KEN O'BYRNE; STEPHEN FOX; RUTH WH 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 819 KB

Tumour angiogenesis is an important factor for tumour growth and metastasis. Although some recent reports suggest that microvessel counts in non-small cell lung cancer are related to a poor disease outcome, the results were not conclusive and were not compared with other molecular prognostic markers